Ph.D of Beijing institute of Ophalmology, China.
Dr. Xianyang Liu is a distinguished ophthalmology researcher affiliated with the Chongqing Eye Research Institute and the Beijing Eye Research Institute. Under the mentorship of the renowned uveitis expert Professor Shengping Hou, Dr. Liu has made significant contributions to the field, publishing over 10 SCI articles in prestigious journals like Cellular & Molecular Immunology and Advanced Science. His work, which includes high-impact research on retinal diseases and immune mechanisms, has earned him invitations to present at major international conferences, including the 2023 European Human Genetics Conference and the 2024 China Ophthalmology and Vision Conference. Dr. Liu’s accolades include the 2023 MCE China Breakthrough Award and recognition as Chongqing Outstanding Student. His expertise spans ophthalmology, immunology, and epigenetics, and his active participation in research projects and academic peer review highlights his commitment to advancing scientific knowledge and excellence in the field.
Dr. Xianyang Liu possesses a robust set of research skills, underscored by his extensive work in ophthalmology, immunology, and epigenetics. His expertise includes a deep understanding of experimental methodologies and digital medicine, enabling him to conduct high-impact research with significant clinical implications. Proficient in advanced experimental techniques, he excels in the use of complex immunological and genetic assays, contributing to influential studies published in prestigious journals. Dr. Liu’s experience extends to reviewing for top academic journals, reflecting his critical insight into research quality and academic rigor. His ability to integrate basic research with practical applications showcases his versatility and depth of knowledge. Additionally, Dr. Liu’s collaborative skills, demonstrated through multi-author publications, and his involvement in diverse research projects highlight his capacity to work effectively within multidisciplinary teams. Overall, his research skills are marked by precision, innovation, and a commitment to advancing scientific understanding in his field.
Dr. Xianyang Liu is a highly qualified candidate for the Best Researcher Award. His specialization in ophthalmology, substantial publication record in high-impact journals, international recognition, and multiple awards underline his excellence and innovation in research. While there are areas for improvement, such as increasing the broader impact of his work and demonstrating more leadership in research projects, Dr. Liu’s achievements make him a strong contender for this award.
Publications Top Notes
- “Icariin alleviates oxygen-induced retinopathy by targeting microglia hexokinase 2”
- Authors: Li, X., Wang, G., Li, N., Zhou, Q., Hou, S.
- Journal: Immunology
- Year: 2024
- Volume: 173(1)
- Pages: 141–151
- “Autophagy-mediated activation of the AIM2 inflammasome enhances M1 polarization of microglia and exacerbates retinal neovascularization”
- Authors: Liu, X., Zhou, Q., Meng, J., Mao, L., Hou, S.
- Journal: MedComm
- Year: 2024
- Volume: 5(8)
- Article Number: e668
- “OR11H1 Missense Variant Confers the Susceptibility to Vogt‒Koyanagi‒Harada Disease by Mediating Gadd45g Expression”
- Authors: Li, X., Wang, G., Wang, X., Yang, P., Hou, S.
- Journal: Advanced Science
- Year: 2024
- Volume: 11(11)
- Article Number: 2306563
- “A de novo missense mutation in MPP2 confers an increased risk of Vogt–Koyanagi–Harada disease as shown by trio-based whole-exome sequencing”
- Authors: Liu, X., Meng, J., Liao, X., Yang, P., Hou, S.
- Journal: Cellular and Molecular Immunology
- Year: 2023
- Volume: 20(11)
- Pages: 1379–1392
- Citations: 4
- “Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics”
- Authors: Li, R., Liu, J., Yi, P., Yang, P., Hou, S.
- Journal: Advanced Science
- Year: 2023
- Volume: 10(16)
- Article Number: 2206623
- Citations: 2
- “Apigenin Alleviates Autoimmune Uveitis by Inhibiting Microglia M1 Pro-Inflammatory Polarization”
- Authors: Shu, N., Zhang, Z., Wang, X., Zhang, L., Hou, S.
- Journal: Investigative Ophthalmology and Visual Science
- Year: 2023
- Volume: 64(5)
- Article Number: 21
- Citations: 8
- “NLRP3 Attenuates Intraocular Inflammation by Inhibiting AIM2-Mediated Pyroptosis Through the Phosphorylated Salt-Inducible Kinase 1/Sterol Regulatory Element Binding Transcription Factor 1 Pathway”
- Authors: Meng, J., Li, N., Liu, X., Yang, P., Hou, S.
- Journal: Arthritis and Rheumatology
- Year: 2023
- Volume: 75(5)
- Pages: 842–855
- Citations: 11
- “N6-methyladenosine demethylase FTO regulates inflammatory cytokine secretion and tight junctions in retinal pigment epithelium cells”
- Authors: Tang, S., Meng, J., Tan, J., Li, N., Hou, S.
- Journal: Clinical Immunology
- Year: 2022
- Volume: 241
- Article Number: 109080
- Citations: 19
- “METTL3 inhibits inflammation of retinal pigment epithelium cells by regulating NR2F1 in an m6A-dependent manner”
- Authors: Meng, J., Liu, X., Tang, S., Li, N., Hou, S.
- Journal: Frontiers in Immunology
- Year: 2022
- Volume: 13
- Article Number: 905211
- Citations: 16
- “LGALS3BP in Microglia Promotes Retinal Angiogenesis through PI3K/AKT Pathway during Hypoxia”
- Authors: Zhao, C., Liu, Y., Meng, J., Li, N., Hou, S.
- Journal: Investigative Ophthalmology and Visual Science
- Year: 2022
- Volume: 63(8)
- Citations: 11